Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial - Yokota, S; Imagawa, T; Mori, M (Lancet, 2008)
et al.